Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Alemtuzumab in the treatment of multiple sclerosis.
Dock3 protects myelin in the cuprizone model for demyelination.
IgM-monoclonal gammopathy neuropathy and tremor: A first epidemiologic case control study.
Multifocal visual evoked potential in optic neuritis, ischemic optic neuropathy and compressive optic neuropathy.
A web-based decision support tool for prognosis simulation in multiple sclerosis.
High avidity chimeric monoclonal antibodies against the extracellular domains of human aquaporin-4 competing with NMO-IgG.
Cognitive-motor related brain activity during walking: differences between men and women with multiple sclerosis.
MRI in the Evaluation of Acute Visual Syndromes.
Levels and actions of neuroactive steroids in the nervous system under physiological and pathological conditions: Sex-specific features.
[Treatment of transplantation of NT-3 gene modified olfactory ensheathing cells on experimental autoimmune encephalomyelitis in rats].
Programmed Death Ligand-1 on Microglia Regulates Th1 Differentiation via Nitric Oxide in Experimental Autoimmune Encephalomyelitis.
Cytokine-Defined B Cell Responses as Therapeutic Targets in Multiple Sclerosis.
Oral fingolimod to treat multiple sclerosis: see your cardiologist first.
Predictors of recurrence following an initial episode of transverse myelitis.
Immune cell dynamics in the CNS: Learning from the zebrafish.
Anti-JC virus antibodies in rituximab-treated patients with neuromyelitis optica spectrum disorder.
Co-occurrence of multiple sclerosis and Thomsen's myotonia: a report of two cases.
The effect of the sphingosine-1-phosphate analogue FTY720 on atrioventricular nodal tissue.
Mast Cell and Autoimmune Diseases.
Moyamoya disease in a patient with neuromyelitis optica.
Role of T Follicular Helper cells in Multiple Sclerosis.
Staying on the job: The relationship between work performance and cognition in individuals diagnosed with multiple sclerosis.
Aquaporin-4 immuneglobulin g testing in 36 consecutive jamaican patients with inflammatory central nervous system demyelinating disease.
Differential upregulation of the hypothetical transmembrane protein 66 (TMEM66) in multiple sclerosis patients with potential inflammatory response.
17β-estradiol replacement therapy protects myelin sheaths in the white matter of middle-aged female ovariectomized rats: a stereological study.
Pages
« first
‹ previous
…
540
541
542
543
544
545
546
547
548
…
next ›
last »